FindTrial
Sign In

Evaluation of bone heath in patients with Rheumatoid Arthritis (RA)

A cross sectional study of evaluation of bone heath in patients with Rheumatoid Arthritis (RA)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/11/029439
Enrollment
200
Registered
2020-11-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z789- Other specified health status Health Condition 2: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Sponsors

Medanta The Medicity
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients fulfilling ACR/EULAR 2010 classification criteria for Rheumatoid arthritis 2 Must have provided written informed consent for participation in the study in the subjectâ??s vernacular language 3 In the opinion of the Investigator/Designee, be able to comply with the study procedures and protocol restrictions

Exclusion criteria

Exclusion criteria: 1 Age 2Patients who do not want to be included in the study 3 Patients on anti resorptive/ bone forming agents OR who has taken such treatment in past 4 Pregnant female

Design outcomes

Primary

MeasureTime frame
To Assess serum levels of OPG and RANKL in Rheumatoid Arthritis (RA) patients with & without osteoporosisTimepoint: 12 months—

Secondary

MeasureTime frame
To study prevalence of osteoporosis in Rheumatoid Arthritis (RA). Timepoint: 12months—

Countries

India

Contacts

Public ContactKuldeep Kumar

G D Goenka University

kuldeep121715@gmail.com9971918887

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026